Free Shipping on purchases over €100

Trofolastin Scar Reducer 10 x 14 cm, 5 Patches

Trofolastin Scar Reducer 10 x 14 cm, 5 Patches

Trofolastin Scar Reducer patches is a product that reduces and prevents hypertrophic or keloid scars from burns and cuts.

Contains 5 patches of 10x14 cm.

SKU: 379263
-15%
20% discount. 2nd unit.
74.70
€88.32
€14.94
/1ud

Pharmaceutical Care

Safe medication sales

Secure shipping

PHARMACEUTICAL RECOMMENDATION

License Number: 7270

Silvia Del Río

A pharmacist specializing in dermocosmetics, skin microbiota, and hygiene will advise and help you with the most suitable treatment.

Ask me

INFO AND TECHNICAL SPECIFICATIONS

Trofolastin patches are made of polyurethane. They have a microporous outer layer. They also have an inner layer consisting of an acrylic plate, which helps the product adhere to the skin. They help reduce hypertrophic scars, whether they have formed recently or have been there for a long time.Help improve symptoms associated with healing wounds or injuries caused by general surgery, burns or cosmetic surgery. They reduce the bumps or ridges that tend to grow on the skin after a healing process. This medical device is flexible, breathable and can adhere to moist skin. It can be worn continuously for 24 hours. It helps to improve the appearance of the affected area of the body. It produces the correct arrangement of collagen fibres. It also acts as a protective shield that protects the scar during sun exposure.

These reducing patches are very useful to prevent the formation of keloids.

Tecnical specifications card

Pharmaceutical advice

You can now consult our team with any questions you may have. We remind you that our chatbot is also available for simpler queries.

Ask us
  • Vendor: Cantabria Labs
  • Vendor address: Calle Mar Mediterrania (Polígono Industrial Torre del Rector), 5-9, 08130 Santa Perpètua de Mogoda, Barcelona, España
  • Phone number: +34 935 747 440
Newsletter

Don’t miss anything

Stay up to date with the latest advances in health, discounts, and pharmaceutical news.